Blood test can help identify the target population to screen for lung cancer

A new study by researchers from the International Agency for Research on Cancer (IARC), published today in JAMA Oncology, demonstrates that a blood test measuring four protein biomarkers can improve the identification of individuals who would later develop lung cancer. These biomarkers may help refine the criteria for including current and former smokers in lung cancer screening programmes, using low-dose computed tomography (CT) scans, aimed at reducing deaths from this common cancer.

Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer
Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins
JAMA Oncol. Published online 12 July 2018;
http://dx.doi.org/10.1001/jamaoncol.2018.2078

Read article

IARC Press Release 262